Owners, management and financials
CVR: 45253295
DKK -44,590,096
Gross profit
Net result: DKK -39,672,013
Novo Holdings A/S (33,33-49,99%), Demetrios Thomas Braddock (5-9,99%)
4 more
CVR · view owners
Søren Sylvester Skjærbæk
Board: Jørgen Søberg Petersen (chair) and 5 members
CVR · view management
Active
Founded 5 December 2024
CVR · view overview
3 employees
CVR · 2026
Owner registered: Novo Holdings A/S
CVR · 17/08/2026
View the full event history
RheumaLogics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Sylvester Skjærbæk. The board consists of Jørgen Søberg Petersen (chair), Alex Thomas Pasteur, Balaji Muralidhar and Gabor Gyulveszi. The company's owners include Novo Holdings A/S, Demetrios Thomas Braddock and F-Prime Capital Partners Life Sciences Fund IX LP. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -44,590,096 and a net result of DKK -39,672,013. Equity in the 2025 report amounted to DKK 22,357,721.
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202505/12/2024 – 31/12/2025 | -44.6M | -39.7M | 71.2M | 22.4M | 1 |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of RheumaLogics ApS is 45253295.
The owners of RheumaLogics ApS include Novo Holdings A/S, Demetrios Thomas Braddock and F-Prime Capital Partners Life Sciences Fund IX LP.
The management of RheumaLogics ApS consists of Søren Sylvester Skjærbæk.
The board of RheumaLogics ApS consists of Jørgen Søberg Petersen, Alex Thomas Pasteur and Balaji Muralidhar, with Jørgen Søberg Petersen as chair.
In 2025, RheumaLogics ApS reported a gross profit of DKK -44,590,096.
RheumaLogics ApS had 3 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of August 17, 2026, Novo Holdings A/S is registered as an owner of RheumaLogics ApS with an ownership share of 33%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 5%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 5%.
As of July 10, 2026, Gabor Gyulveszi has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Alex Thomas Pasteur has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Balaji Muralidhar has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Megan Shea Lipcsey has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Marianne Uteng has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Reinaldo Miguel Diaz has left the board of directors of RheumaLogics ApS.
RheumaLogics ApS has published its annual report for 2025. Gross profit came to DKK -44,590,096, and the net result was DKK -39,672,013.
As of June 22, 2026, Søren Sylvester Skjærbæk is registered as director of RheumaLogics ApS.
As of June 22, 2026, Jørgen Søberg Petersen has stepped down as director of RheumaLogics ApS.
As of December 5, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of RheumaLogics ApS.
As of December 5, 2024, Jørgen Søberg Petersen has joined the board of directors of RheumaLogics ApS.
As of December 5, 2024, Reinaldo Miguel Diaz has joined the board of directors of RheumaLogics ApS.
As of December 5, 2024, Jørgen Søberg Petersen is registered as director of RheumaLogics ApS.
RheumaLogics ApS was founded on December 5, 2024.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 26333210
CVR 41366044
CVR 27701396
CVR 33992890
CVR 43932489
